“food-and-drug-administration” Archives

in
Entry Author Date Location
Lilly Nixes Expansion of Stomach Cancer Drug After Mixed Study Results 12/11/17 Indiana
Gilead Bets on Cell Therapy Again with $567M Cell Design Labs Deal 12/07/17 San Francisco
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
Drug Prices, Industry Ties Take Spotlight at HHS Nominee Azar Hearing 11/29/17 National
Chemo Tops Pfizer, Merck KGaA Drug in Big Stomach Cancer Test 11/28/17 New York
Acorda Scraps One Parkinson’s Drug, Puts Its Cash Behind Another 11/20/17 New York
Locus Bio Raises $19M for CRISPR-Cas3 Antimicrobial “Smart Bombs” 11/14/17 Raleigh Durham
With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer 11/14/17 Boston
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More 11/03/17 National
Scangos Heats Up Xconomy’s What’s Hot in Bay Area Biotech Lineup 11/02/17 San Francisco
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s 10/31/17 Boston
No Charm: PTC’s Duchenne Drug Rejected by FDA for Third Time 10/25/17 New York
With New Funding, TAI Diagnostics Set to Launch Post-Transplant Test 10/24/17 Wisconsin
Arsanis Eyes IPO to Support Clinical Testing of Pneumonia Drug 10/23/17 Boston
For Key Study, UniQure Allowed to Swap Hemophilia Gene Therapies 10/19/17 Boston
Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact 10/18/17 Indiana
After FDA Nod, TransEnterix Preps to Bring Surgical Robot to Market 10/17/17 Raleigh Durham
Bio Roundup: Light For Spark, California Drug Law, IPO Queue & More 10/13/17 National
Spark’s Gene Therapy to Restore Vision Wins Unanimous FDA Panel Vote 10/12/17 New York
OrthoPediatrics IPO Raises $52M for Medical Implants and Instruments 10/12/17 Indiana
Merck Abandons Plans to Seek FDA Approval of Cholesterol Drug 10/11/17 New York
FDA To Advisors: What If One-Time Gene Therapy Needs Extra Doses? 10/10/17 National
KalVista, Merck Partnership on Blindness Drug Sends Shares Skyward 10/10/17 Boston
Eli Lilly Drug Fails in Lung Cancer, Stalling Oncology Strategy 10/10/17 Indiana
Rhythm Pharma IPO Pops to the Tune of a $120M Upsized Offering 10/05/17 Boston
Amicus Therapeutics’ Pompe Drug Data Show Improved Muscle Movement 10/04/17 New York
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
Deciphera IPO Drums Up $128M for Cancer Drug Studies 09/28/17 Boston
A4L Lands $25M for Imaging Tech that Reads Heart’s Electric Signals 09/27/17 Raleigh Durham
Landos Joins Garabedian’s Bio Startup Accelerator Xontogeny, Gets $10M 09/21/17 Boston
Page 1 of 8 next page »